| What's Making News At Keryx? - RTT News |
|
|
RTT News The 58-week long-term safety and efficacy study of Zerenex, which was initiated in September 2010, is ongoing and has an estimated enrollment of approximately 300 ESRD patients on hemodialysis or peritoneal dialysis. The patients are randomized 2:1 to |